Bristol-Myers Squibb Co - 30d expiry - We look to Sell a break of 65.18 (stop at 67.68)
Daily signals are bearish.
There is no clear indication that the downward move is coming to an end.
65.95 has been pivotal.
A break of the recent low at 65.28 should result in a further move lower.
Price action is forming a bearish flag which has a bias to break to the...
$BMY has held up remarkably well during the market sell off. That said, I don't think that it's going to escape the downside for that much longer.
We've tested the $77-78 region multiple times and just rejected again. Seeing the price action today makes me think that it's finally time for BMY to fall lower. Once $BMY breaks $75, there's not much holding it up. I...
Immediate targets 61, 59, 56, 53. Invalidation at 79.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically...
Trade Idea
Enter Long
- Ideal price is $64-$66
Stop Loss
- $64.4
Profit Target
- $70-$71
ARK fund is dumping Bristol-Myers Squibb (BMY), should you?
Yet another solid company with solid financials who is currently trading at 65.6% below estimated fair values. Earnings are forecasted to grow 30.88% per year. This stock also pays out a reliable dividend of...
When I say "historic" for BMY I'm not talking ATH but the stock's encroaching on an area that has been tested 3 times being rejected each time. This is the 236 fib area using 2016's high as the top anchor. It's been 5 years since BMY traded well above this area. But with the way attention is being placed on immunotherapy stocks, it could be something to keep in...
A complex correction, looking to continue. Down we go. Seeking to test or break the floor first and then the two fib goals traced. Not financial advice.
Hey everyone,
Another biomed related post today by request.
BMY has double-bottomed as bulls grab a little control today on price.
The stock has respected the BBands and is looking to move to the neutral region.
The RSI teased in the oversold area, and price has responded with one of the two strong bull movements in the past four weeks as far as price movement...
After a month of sharp sell-off, we're looking at a red 9 on the TD sequential indicator, the RSI is oversold, and we're sitting at a previous support level. I think we can safely expect at least a dead cat bounce, if not a reversal. Keep watch, do your own research. good luck
On April 13, 2017, the Bristol-Myers Squibb ( BMY ) 20 day moving average (DMA) crossed below the 50 and 150 DMA. Both events have never occurred before on the same day. Historically 20 has crossed below the 50 DMA 129 times, and the 20 has crossed below the 150 DMA 53 times. For all of these instances, the stock does not always drop over the following 13 trading...
Similar upward pattern found in past. Health care is booming for last couple weeks, which confirms this is indeed a industry trend. BMY should reach at least up to $57 in 10 days but not sure what will happen after. Moving Average Convergence Divergence looks pretty solid. Buy now $55 and sell at $57 make $2 per share in 10 days.
Just an idea about BMY. Is this a "cup with handle" or "island reveresal?" or "rounding bottom"? Actually is out and close to going up (if patterns are right).
In RED: rounding bottom
in GREEN: cup with handle
what do you think about BMY? I have find no ideas to compare my points of view, thank in advance for feedback!
